Lorazepam 0.5 mg/0.1 ml Nasal Spray is a compounded liquid formulation, specifically designed for nasal administration. It is used to treat conditions such as Anxiety, Insomnia, Panic Disorder, Agitation, and Depression, providing targeted local or systemic effects through the nostrils.

Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Lorazepam 0.5 mg/0.1 ml Nasal Spray is a specially compounded medication designed to treat a range of conditions including anxiety, insomnia, and seizures. This unique formulation is delivered in a liquid spray form, specifically designed for administration into the nasal cavity. The medication is absorbed directly through the nasal mucosa, providing a fast-acting, non-invasive, and convenient method of drug delivery.
Its rapid onset of action makes it an ideal choice for conditions that require immediate relief. The non-invasive nature of this nasal spray also makes it a convenient option for patients who may have difficulty with other forms of medication administration.
At Bayview Pharmacy, we are proud to offer this unique formulation of Lorazepam Nasal Spray. Our team of experienced compounding pharmacists are always available to answer any questions you may have about this formulation, its use, and its potential benefits. We are committed to providing the highest quality of care and service to our patients. If you have any questions or concerns, please do not hesitate to reach out to us.
This compounded formulation of Lorazepam 0.5 mg/0.1 ml Nasal Spray is a liquid formulation delivered in a spray form, specifically designed for administration into the nasal cavity. It provides targeted local or systemic effects through the nostrils and is indicated for the treatment of anxiety, insomnia, and seizures. It is important to use this medication with caution, particularly in patients with a history of depression, suicidal thoughts, or substance abuse.
Patients using this formulation should be closely monitored for signs of sedation, respiratory depression, and other potential adverse effects. It is crucial to note that Lorazepam should not be used in combination with other benzodiazepines, alcohol, or other CNS depressants. This is due to the increased risk of severe sedation, respiratory depression, and even death.
Patients should be advised to avoid activities requiring mental alertness such as driving or operating machinery until they are certain about the medication's effects on them. Concurrent consumption of alcohol while on this medication should also be avoided as it can exacerbate the sedative effects of Lorazepam.
It is also important to monitor patients for signs of withdrawal if the medication is stopped abruptly. Withdrawal symptoms can be severe and may include seizures, psychosis, and even death. Therefore, it is recommended to gradually reduce the dose of Lorazepam under the supervision of a healthcare professional.
If any questions or concerns arise regarding the use of this compounded formulation of Lorazepam 0.5 mg/0.1 ml Nasal Spray, please do not hesitate to reach out for further assistance.
Lorazepam 0.5 mg/0.1 ml Nasal Spray is a specially compounded medication, designed to treat a range of conditions such as anxiety, insomnia, seizures, and muscle spasms. This unique formulation is administered via a nasal spray, allowing for the active ingredient, lorazepam, to be absorbed directly through the nasal mucous membranes.
Lorazepam is a benzodiazepine that functions by binding to GABA receptors in the brain. This action helps to alleviate anxiety and promote a sense of relaxation. The nasal spray delivery method provides a targeted approach, ensuring the medication is delivered where it is most needed.
When using Lorazepam 0.5 mg/0.1 ml Nasal Spray, it is crucial to adhere to the instructions provided by your healthcare provider. Typically, the recommended dosage is one spray in each nostril once or twice daily. Overuse or misuse of this medication can lead to severe side effects, hence the importance of following the prescribed dosage.
Patients should be aware that Lorazepam 0.5 mg/0.1 ml Nasal Spray may cause side effects such as drowsiness, dizziness, and blurred vision. It is advised to avoid activities that require alertness, such as driving or operating heavy machinery, until you understand how the medication affects you. Additionally, alcohol consumption should be avoided while on this medication, as it can exacerbate the risk of side effects.
Healthcare providers should note that Lorazepam 0.5 mg/0.1 ml Nasal Spray may interact with other medications, including certain antibiotics, antifungals, and antidepressants. Therefore, it is essential to review the patient's current medication list before prescribing this nasal spray. Regular monitoring of the patient for signs of addiction or abuse is also crucial due to the nature of the active ingredient.
If you have any queries or concerns about Lorazepam 0.5 mg/0.1 ml Nasal Spray, please do not hesitate to reach out for further information.
Lorazepam 0.5 mg/0.1 ml Nasal Spray is a liquid formulation of the medication Lorazepam, designed to be administered into the nasal cavity. It is delivered in a spray form for targeted local or systemic effects through the nostrils.
The nasal spray works by delivering the medication directly into the nasal cavity. This allows for quick absorption into the bloodstream, providing targeted local or systemic effects.
You should use the nasal spray as directed by your healthcare provider. Typically, the spray is administered into the nostrils.
As with any medication, Lorazepam nasal spray can have side effects. These may include drowsiness, dizziness, or a temporary burning sensation in the nose. Always consult your healthcare provider for a complete list of potential side effects.
No, this medication should only be used by individuals for whom it has been prescribed, and who have been instructed on its proper use by a healthcare provider.
If you have a cold or nasal congestion, it may affect the absorption of the medication. It's best to consult your healthcare provider in such cases.
It's important to discuss all medications you're currently taking with your healthcare provider before starting Lorazepam nasal spray, as it may interact with other drugs.
Store the nasal spray at room temperature, away from light and moisture. Do not store in the bathroom. Keep all medications away from children and pets.
If you miss a dose, use it as soon as you remember. If it is near the time of the next dose, skip the missed dose. Use your next dose at the regular time. Do not double the dose to catch up.
If someone has overdosed and has serious symptoms such as passing out or trouble breathing, call emergency services immediately. Symptoms of overdose may include severe drowsiness, confusion, loss of consciousness.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.
This preparation is a controlled substance. Additional prescribing, refill, and shipping restrictions apply, and the states Bayview can dispense it to are narrower than for non-controlled preparations.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Inhale intranasally